Trial intelligence / Profile preview

Methylphenidate for Learning Impairments in Childhood Cancer Survivors

NCT00576472Phase 4Completed

Sponsor
St. Jude Children's Research Hospital
Start
Jan 2000
Primary completion
Mar 2010
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of methylphenidate in cognitive impairment, sponsored by St. Jude Children's Research Hospital. Started Jan 2000; status: completed.

02

Drugs

methylphenidate
03

Conditions

cognitive impairment

Beyond the preview

Go deeper on NCT00576472.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00576472.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call